Austco Healthcare Limited
Austco Healthcare Limited Fundamental Analysis
Austco Healthcare Limited (AHC.AX) shows moderate financial fundamentals with a PE ratio of 18.39, profit margin of 8.36%, and ROE of 14.03%. The company generates $0.1B in annual revenue with strong year-over-year growth of 38.53%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 69.1/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze AHC.AX's fundamental strength across five key dimensions:
Efficiency Score
WeakAHC.AX struggles to generate sufficient returns from assets.
Valuation Score
ExcellentAHC.AX trades at attractive valuation levels.
Growth Score
ModerateAHC.AX shows steady but slowing expansion.
Financial Health Score
ExcellentAHC.AX maintains a strong and stable balance sheet.
Profitability Score
WeakAHC.AX struggles to sustain strong margins.
Key Financial Metrics
Is AHC.AX Expensive or Cheap?
P/E Ratio
AHC.AX trades at 18.39 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, AHC.AX's PEG of 0.60 indicates potential undervaluation.
Price to Book
The market values Austco Healthcare Limited at 2.43 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 10.95 times EBITDA. This signals the market has high growth expectations.
How Well Does AHC.AX Make Money?
Net Profit Margin
For every $100 in sales, Austco Healthcare Limited keeps $8.36 as profit after all expenses.
Operating Margin
Core operations generate 11.85 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $14.03 in profit for every $100 of shareholder equity.
ROA
Austco Healthcare Limited generates $8.86 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Austco Healthcare Limited produces operating cash flow of $20.61M, showing steady but balanced cash generation.
Free Cash Flow
Austco Healthcare Limited generates strong free cash flow of $17.60M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.05 in free cash annually.
FCF Yield
AHC.AX converts 12.21% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
18.39
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.60
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.43
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.56
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.13
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.15
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.14
vs 25 benchmark
ROA
Return on assets percentage
0.09
vs 25 benchmark
ROCE
Return on capital employed
0.17
vs 25 benchmark
How AHC.AX Stacks Against Its Sector Peers
| Metric | AHC.AX Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 18.39 | 28.25 | Better (Cheaper) |
| ROE | 14.03% | 780.00% | Weak |
| Net Margin | 8.36% | -20122.00% (disorted) | Weak |
| Debt/Equity | 0.13 | 0.30 | Strong (Low Leverage) |
| Current Ratio | 2.15 | 4.66 | Strong Liquidity |
| ROA | 8.86% | -14687.00% (disorted) | Weak |
AHC.AX outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Austco Healthcare Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
40.77%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
752.48%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
513.24%
Industry Style: Defensive, Growth, Innovation
High Growth